---
figid: PMC3022188__SRCM2011-756982.001
figlink: /pmc/articles/PMC3022188/figure/fig1/
number: Figure 1
caption: Rationale for dual treatment targeting the IGF-1R signaling pathway in RMS.
  Rapamycin inhibits mTOR signaling, preventing inhibitory feedback on IRS-1 which
  allows proliferative signals from IGF-1R to IRS-1, PI3K, and AKT. Dual treatment
  using rapamycin in combination with IGF-1R inhibition, such as monoclonal blocking
  antibodies, prevents signaling to these critical progrowth signaling nodes.
pmcid: PMC3022188
papertitle: Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma.
reftext: Lisa E. S. Crose, et al. Sarcoma. 2011;2011:756982.
pmc_ranked_result_index: '43298'
pathway_score: 0.9588316
filename: SRCM2011-756982.001.jpg
figtitle: Rationale for dual treatment targeting the IGF-1R signaling pathway in RMS
year: '2011'
organisms: Homo sapiens
ndex: 95e84c6b-deb4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3022188__SRCM2011-756982.001.html
  '@type': Dataset
  description: Rationale for dual treatment targeting the IGF-1R signaling pathway
    in RMS. Rapamycin inhibits mTOR signaling, preventing inhibitory feedback on IRS-1
    which allows proliferative signals from IGF-1R to IRS-1, PI3K, and AKT. Dual treatment
    using rapamycin in combination with IGF-1R inhibition, such as monoclonal blocking
    antibodies, prevents signaling to these critical progrowth signaling nodes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3R5
  - MTOR
  - IRS1
  - AKT1
  - AKT3
  - PIK3CA
  - IGF1R
  - PIK3CD
  - PIK3CG
  - AKT2
  - PIK3R6
  - PIK3CB
  - PIK3R3
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals: []
diseases: []
---
